Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alimera enters agreement with Emory to develop new drugs for ophthalmic diseases

Feb. 29, 2008

Sirion and Bridge enter agreement for topical ophthalmic drugs containing norketotifen

Feb. 27, 2008

Positive preliminary results reported from MacuSight's phase I sirolimus study

Feb. 26, 2008

Recent Allergan patents disclose new therapeutics for glaucoma

Feb. 13, 2008

Biovitrum completes exploratory phase II study of BVT-28949 in glaucoma

Feb. 13, 2008

New treatment alternative for glaucoma imparted in recent Allergan patent

Feb. 11, 2008

Advanced Cell Technology completes pre-IND meeting with FDA for RPE cell therapy

Feb. 6, 2008

LX-201 granted fast track designation for corneal transplant rejection

Jan. 31, 2008

Recent Merck & Co. patent imparts novel agents for ocular disorders

Jan. 24, 2008

Can-Fite expands studies to further investigate efficacy of CF-101 in treating uveitis

Jan. 18, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...